Status:
COMPLETED
Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study
Lead Sponsor:
Mayo Clinic
Conditions:
Breast Carcinoma
Head and Neck Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time...
Detailed Description
PRIMARY OBJECTIVES: I. Evaluate the data aggregation from a patient centered platform over a follow up period for completeness and quality, including externally linked electronic health record (EHR) ...
Eligibility Criteria
Inclusion
- Age 18+
- English speaking
- Consented for Outcomes Registry Study (15-000136)
- Undergoing radiotherapy for cancer treatment with curative intent
- Willing to and able to give consent and participate in study
- Willing to complete all surveys
- Able to access a device (computer, smartphone, or tablet) with web access every day to complete study surveys
- Willing to connect to a device (i.e., a smartphone, Fitbit, or tablet) that can regularly link to Hugo for data transfer
- Willing to share personal information to Tremendous to be able to obtain the Visa e-cards for time and effort put into this study
- Willing to use the Hugo health data sharing platform
- Willing to create a Mayo Clinic Patient Portal (if not already created)
Exclusion
- Unable to give consent and enroll prior to administration of baseline survey
- Partial breast radiation therapy (RT) (3 fraction), due to overlap in cadence used for all disease sites
- Stereotactic body radiation therapy (SBRT) to the lung, due to overlap in cadence used for all disease sites
- Co-enrollment on another PRO related study (soft rule)
- Coordinator would need to get source data from Adam via Hugo
- Response data will only be accessible by select people
Key Trial Info
Start Date :
March 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05224271
Start Date
March 2 2022
End Date
April 10 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905